Consumer health continues to experience high retail current value growth in 2023, albeit at a slower rate than 2022. Higher costs of materials, ingredients and services are naturally leading to strong price increases in 2023, thereby driving up value growth. The bulk of absolute growth in 2023 has come from OTC categories, with cough, cold and allergy (hay fever) remedies recording consecutive years of dynamic growth due to the strong 2022 cold and flu continuing into Q1 2023. The broader OTC ma...
Euromonitor International's Consumer Health in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report? * Get a detailed picture of the Consumer Health market; * Pinpoint growth sectors and identify factors driving change; * Understand the competitive environment, the market’s major players and leading brands; * Use five-year forecasts to assess how the market is predicted to develop.
Consumer Health in the United Kingdom
Euromonitor International
September 2023
List Of Contents And Tables
CONSUMER HEALTH IN THE UNITED KINGDOM
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 2 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2018-2023
Table 4 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 5 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 6 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 8 Distribution of Consumer Health by Format: % Value 2018-2023
Table 9 Distribution of Consumer Health by Format and Category: % Value 2023
Table 10 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2022-2023
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources
ANALGESICS IN THE UNITED KINGDOM
KEY DATA FINDINGS
2023 DEVELOPMENTS
Slower growth for analgesics in 2023 following strong cold and flu season in 2022
Consumers trade down to private label amid cost-of-living crisis
Regulatory change provides opportunity for topical analgesics/anaesthetic
PROSPECTS AND OPPORTUNITIES
Growth expected to slow but more focused advertising provides opportunities
Topical format expected to outperform other types of analgesics
E-commerce sales likely to remain elevated over the forecast period
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2018-2023
Table 13 Sales of Analgesics by Category: % Value Growth 2018-2023
Table 14 NBO Company Shares of Analgesics: % Value 2019-2023
Table 15 LBN Brand Shares of Analgesics: % Value 2020-2023
Table 16 Forecast Sales of Analgesics by Category: Value 2023-2028
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN THE UNITED KINGDOM
KEY DATA FINDINGS
2023 DEVELOPMENTS
Category benefits from stronger cold and flu season in Q1 2023
Fexofenadine switch continues to drive allergy growth